These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16200342)

  • 1. Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression.
    Carlsson J; Ren ZP; Wester K; Sundberg AL; Heldin NE; Hesselager G; Persson M; Gedda L; Tolmachev V; Lundqvist H; Blomquist E; Nistér M
    J Neurooncol; 2006 Mar; 77(1):33-45. PubMed ID: 16200342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EGFRvIII variant in glioblastoma multiforme.
    Gan HK; Kaye AH; Luwor RB
    J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme.
    Li L; Quang TS; Gracely EJ; Kim JH; Emrich JG; Yaeger TE; Jenrette JM; Cohen SC; Black P; Brady LW
    J Neurosurg; 2010 Aug; 113(2):192-8. PubMed ID: 20345222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.
    Li W; Wu C; Yao Y; Dong B; Wei Z; Lv X; Zhang J; Xu Y
    Neurosci Lett; 2014 Apr; 566():82-7. PubMed ID: 24582898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EGFR in Paired New and Recurrent Glioblastomas.
    Cioca A; Olteanu EG; Gisca MD; Morosanu CO; Marin I; Florian IS
    Asian Pac J Cancer Prev; 2016; 17(9):4205-4208. PubMed ID: 27797218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments.
    Reulen HJ; Suero Molina E; Zeidler R; Gildehaus FJ; Böning G; Gosewisch A; Stummer W
    Acta Neurochir (Wien); 2019 Jun; 161(6):1109-1124. PubMed ID: 30980242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group.
    Chakravarti A; Seiferheld W; Tu X; Wang H; Zhang HZ; Ang KK; Hammond E; Curran W; Mehta M
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):318-27. PubMed ID: 15890570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells.
    Struve N; Riedel M; Schulte A; Rieckmann T; Grob TJ; Gal A; Rothkamm K; Lamszus K; Petersen C; Dikomey E; Kriegs M
    Oncotarget; 2015 Oct; 6(32):33867-77. PubMed ID: 26418954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status.
    Navarro L; Gil-Benso R; Megías J; Muñoz-Hidalgo L; San-Miguel T; Callaghan RC; González-Darder JM; López-Ginés C; Cerdá-Nicolás MJ
    Neuroscience; 2015 Jun; 297():243-51. PubMed ID: 25869624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of Notch-1 and EGFR induced apoptosis in glioblastoma multiforme patients.
    Xing ZY; Sun LG; Guo WJ
    Clin Neurol Neurosurg; 2015 Apr; 131():54-8. PubMed ID: 25704190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
    Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
    Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erlotinib: early clinical development in brain cancer.
    Addeo R; Zappavigna S; Parlato C; Caraglia M
    Expert Opin Investig Drugs; 2014 Jul; 23(7):1027-37. PubMed ID: 24836441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma.
    Pöpperl G; Götz C; Rachinger W; Schnell O; Gildehaus FJ; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):792-800. PubMed ID: 16550381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.
    Stockhausen MT; Broholm H; Villingshøj M; Kirchhoff M; Gerdes T; Kristoffersen K; Kosteljanetz M; Spang-Thomsen M; Poulsen HS
    Exp Cell Res; 2011 Jul; 317(11):1513-26. PubMed ID: 21514294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric glioblastomas: a histopathological and molecular genetic study.
    Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C
    Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.
    Chakravarti A; Loeffler JS; Dyson NJ
    Cancer Res; 2002 Jan; 62(1):200-7. PubMed ID: 11782378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
    Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.